Related Experiment Video
Updated: Mar 25, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
The harmful effect of indoxyl sulfate on neovascularization in chronic kidney disease
Laetitia Dou1, Stéphane Burtey2
1Aix Marseille Université, Inserm, Vascular Research Center of Marseille UMR_S 1076, Marseille, France.
Abstract:
Patients with chronic kidney disease display an impairment of neovascularization in ischemic tissues. Studies have suggested the involvement of the uremic toxin indoxyl sulfate by demonstrating that indoxyl sulfate affects endothelial progenitor cells. However, few data are available on the effects of indoxyl sulfate on neovascularization and on the mechanisms involved. The article by Hung et al. shows that indoxyl sulfate suppresses neovascularization in uremic mice by impairing endothelial progenitor cell function via the inhibition of hypoxia-induced hypoxia-inducible factor/interleukin-10/vascular endothelial growth factor signaling.
Insights
Chronic kidney disease impairs blood vessel formation. Indoxyl sulfate, a toxin, blocks this process by inhibiting key signaling pathways in endothelial progenitor cells.
Area of Science:
- Nephrology
- Vascular Biology
- Molecular Medicine
Background:
- Patients with chronic kidney disease (CKD) exhibit impaired neovascularization in ischemic tissues.
- The uremic toxin indoxyl sulfate is implicated in endothelial progenitor cell dysfunction.
- Limited data exist on indoxyl sulfate's specific effects on neovascularization and its underlying mechanisms.
Purpose of the Study:
- To investigate the impact of indoxyl sulfate on neovascularization in a CKD model.
- To elucidate the molecular mechanisms by which indoxyl sulfate affects neovascularization.
Main Methods:
- Utilized a mouse model of uremia to study neovascularization.
- Assessed endothelial progenitor cell function and signaling pathways.
- Investigated the role of hypoxia-induced factor (HIF) signaling.
Main Results:
- Indoxyl sulfate significantly suppressed neovascularization in uremic mice.
- Impaired endothelial progenitor cell function was observed.
- Indoxyl sulfate inhibited the hypoxia-induced HIF/interleukin-10/vascular endothelial growth factor signaling pathway.
Conclusions:
- Indoxyl sulfate is a key factor contributing to impaired neovascularization in CKD.
- The inhibition of the HIF/IL-10/VEGF pathway by indoxyl sulfate underlies this impairment.
- Targeting this pathway may offer therapeutic potential for CKD-related vascular complications.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury I: Introduction
Chronic Kidney Disease I: Introduction

